OppenheimerFunds Inc. grew its position in shares of Aetna Inc (NYSE:AET) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,279,841 shares of the company’s stock after purchasing an additional 41,616 shares during the quarter. Aetna comprises approximately 0.7% of OppenheimerFunds Inc.’s investment portfolio, making the stock its 22nd largest position. OppenheimerFunds Inc. owned approximately 1.00% of Aetna worth $591,650,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in AET. Assenagon Asset Management S.A. bought a new position in Aetna during the 3rd quarter worth approximately $3,530,000. Robeco Institutional Asset Management B.V. raised its holdings in Aetna by 39.7% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 60,170 shares of the company’s stock worth $9,568,000 after purchasing an additional 17,103 shares during the last quarter. Rockefeller Financial Services Inc. raised its holdings in Aetna by 262.0% during the 3rd quarter. Rockefeller Financial Services Inc. now owns 3,620 shares of the company’s stock worth $576,000 after purchasing an additional 2,620 shares during the last quarter. Oakbrook Investments LLC raised its holdings in Aetna by 46.0% during the 3rd quarter. Oakbrook Investments LLC now owns 19,134 shares of the company’s stock worth $3,042,000 after purchasing an additional 6,025 shares during the last quarter. Finally, LS Investment Advisors LLC raised its holdings in Aetna by 6.1% during the 3rd quarter. LS Investment Advisors LLC now owns 9,466 shares of the company’s stock worth $1,505,000 after purchasing an additional 545 shares during the last quarter. Hedge funds and other institutional investors own 84.88% of the company’s stock.

Get Aetna alerts:

Shares of Aetna Inc (AET) opened at $178.03 on Wednesday. The firm has a market cap of $58,362.50, a price-to-earnings ratio of 30.96, a PEG ratio of 1.45 and a beta of 0.60. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.68 and a quick ratio of 0.53. Aetna Inc has a one year low of $124.84 and a one year high of $194.40.

Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The business had revenue of $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. During the same quarter last year, the firm posted $0.08 EPS. Aetna’s revenue was down 6.2% compared to the same quarter last year. analysts expect that Aetna Inc will post 10.99 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Thursday, January 11th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.12%. The ex-dividend date was Wednesday, January 10th. Aetna’s payout ratio is currently 34.78%.

AET has been the subject of several analyst reports. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Cantor Fitzgerald lowered shares of Aetna from an “overweight” rating to a “neutral” rating in a report on Thursday, October 26th. BMO Capital Markets raised their price target on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a report on Friday, October 27th. Jefferies Group raised their price target on shares of Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a report on Wednesday, November 1st. Finally, Citigroup raised their price target on shares of Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a report on Thursday, November 2nd. Nine analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Aetna presently has a consensus rating of “Buy” and a consensus target price of $189.50.

TRADEMARK VIOLATION WARNING: This story was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/21/oppenheimerfunds-inc-has-591-65-million-holdings-in-aetna-inc-aet.html.